Charles desBordes

751 total citations
21 papers, 599 citations indexed

About

Charles desBordes is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Charles desBordes has authored 21 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Charles desBordes's work include Cancer, Hypoxia, and Metabolism (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Histone Deacetylase Inhibitors Research (4 papers). Charles desBordes is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Metabolism, Diabetes, and Cancer (7 papers) and Histone Deacetylase Inhibitors Research (4 papers). Charles desBordes collaborates with scholars based in United States and Singapore. Charles desBordes's co-authors include Michael A. Lea, Verrell M. Randolph, Andrew M. Bauer, Cynthia Besch‐Williford, Chinwe Ibeh, Byung-Eun Kim, Leslie G. Newton, Dennis B. Lubahn, J. Kevin Day and Tim Hui-Ming Huang and has published in prestigious journals such as Cancer Research, Journal of Nutrition and International Journal of Cancer.

In The Last Decade

Charles desBordes

20 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles desBordes United States 14 424 160 79 77 65 21 599
Birdal Bilir United States 11 297 0.7× 107 0.7× 91 1.2× 75 1.0× 58 0.9× 16 584
Tabitha M. Hardy United States 7 444 1.0× 132 0.8× 112 1.4× 63 0.8× 144 2.2× 12 732
Nantiga Virgona Japan 18 336 0.8× 123 0.8× 49 0.6× 68 0.9× 47 0.7× 34 611
Melissa A. Babcook United States 8 293 0.7× 134 0.8× 49 0.6× 96 1.2× 26 0.4× 15 497
Xinying Zhu China 12 403 1.0× 199 1.2× 35 0.4× 64 0.8× 27 0.4× 16 664
Ka Lung Cheung United States 12 825 1.9× 64 0.4× 41 0.5× 86 1.1× 53 0.8× 16 971
Amruta Ronghe United States 10 424 1.0× 141 0.9× 52 0.7× 63 0.8× 44 0.7× 14 597
Rémy Bosviel France 13 406 1.0× 114 0.7× 132 1.7× 55 0.7× 147 2.3× 18 589
Trinath P. Das United States 17 447 1.1× 151 0.9× 46 0.6× 206 2.7× 34 0.5× 21 840
Julie A. Arlotti United States 15 458 1.1× 104 0.7× 63 0.8× 89 1.2× 28 0.4× 19 775

Countries citing papers authored by Charles desBordes

Since Specialization
Citations

This map shows the geographic impact of Charles desBordes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles desBordes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles desBordes more than expected).

Fields of papers citing papers by Charles desBordes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles desBordes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles desBordes. The network helps show where Charles desBordes may publish in the future.

Co-authorship network of co-authors of Charles desBordes

This figure shows the co-authorship network connecting the top 25 collaborators of Charles desBordes. A scholar is included among the top collaborators of Charles desBordes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles desBordes. Charles desBordes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lea, Michael A., et al.. (2019). Abstract 4734: Response of bladder and colon cancer cells to combined treatment with bromodomain and histone deacetylase inhibitors. Cancer Research. 79(13_Supplement). 4734–4734. 1 indexed citations
3.
Lea, Michael A., et al.. (2018). Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells. Anticancer Research. 38(9). 5003–5011. 15 indexed citations
5.
Lea, Michael A., et al.. (2016). Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.. PubMed. 36(4). 1479–88. 44 indexed citations
6.
Lea, Michael A., et al.. (2015). Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism.. PubMed. 35(11). 5889–99. 33 indexed citations
7.
8.
Lea, Michael A., et al.. (2013). Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides.. PubMed. 33(2). 401–7. 12 indexed citations
10.
Lea, Michael A., et al.. (2011). Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin.. PubMed. 31(2). 421–6. 38 indexed citations
11.
12.
Lea, Michael A., Chinwe Ibeh, Jill K. Deutsch, Imran Hamid, & Charles desBordes. (2010). Inhibition of growth and induction of alkaline phosphatase in colon cancer cells by flavonols and flavonol glycosides.. PubMed. 30(9). 3629–35. 19 indexed citations
13.
Lea, Michael A., et al.. (2010). Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells.. PubMed. 30(2). 311–8. 21 indexed citations
14.
Lea, Michael A., Chinwe Ibeh, Charles desBordes, et al.. (2008). Inhibition of growth and induction of differentiation of colon cancer cells by peach and plum phenolic compounds.. Anticancer Research. 28(4B). 2067–76. 22 indexed citations
15.
Lea, Michael A., et al.. (2004). Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules. Cancer Chemotherapy and Pharmacology. 54(1). 57–63. 31 indexed citations
16.
Lea, Michael A., et al.. (2004). Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.. PubMed. 24(5A). 2765–71. 63 indexed citations
17.
Day, J. Kevin, Andrew M. Bauer, Charles desBordes, et al.. (2002). Genistein Alters Methylation Patterns in Mice. Journal of Nutrition. 132(8). 2419S–2423S. 149 indexed citations
18.
Lea, Michael A., et al.. (2002). Induction of Histone Acetylation and Inhibition of Growth of Mouse Erythroleukemia Cells by S-Allylmercaptocysteine. Nutrition and Cancer. 43(1). 90–102. 61 indexed citations
19.
Phoon, Meng Chee, Charles desBordes, J. Howe, & Vincent Chow. (2001). LINOLEIC AND LINOLELAIDIC ACIDS DIFFERENTIALLY INFLUENCE PROLIFERATION AND APOPTOSIS OF MOLT‐4 LEUKAEMIA CELLS. Cell Biology International. 25(8). 777–784. 21 indexed citations
20.
Lea, Michael A., et al.. (2001). Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. International Journal of Cancer. 92(6). 784–789. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026